DHG Stock Overview
DHG Pharmaceutical Joint Stock Company, junto con sus filiales, se dedica a la fabricación y venta de productos farmacéuticos principalmente en Vietnam.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
DHG Pharmaceutical Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫115,400.00 |
| 52 Week High | ₫140,000.00 |
| 52 Week Low | ₫91,200.00 |
| Beta | 0.52 |
| 1 Month Change | 5.97% |
| 3 Month Change | 6.95% |
| 1 Year Change | 26.12% |
| 3 Year Change | 16.21% |
| 5 Year Change | -0.52% |
| Change since IPO | 180.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| DHG | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | -0.9% | -0.5% | -2.3% |
| 1Y | 26.1% | 26.4% | 16.5% |
Rentabilidad frente al sector: DHG igualó al sector VN Pharmaceuticals , que obtuvo un rendimiento del 26.5% el año pasado.
Rentabilidad vs. Mercado: DHG superó al mercado VN, que obtuvo un rendimiento del 20.1% el año pasado.
Price Volatility
| DHG volatility | |
|---|---|
| DHG Average Weekly Movement | 2.8% |
| Pharmaceuticals Industry Average Movement | 3.0% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in VN Market | 6.8% |
| 10% least volatile stocks in VN Market | 2.1% |
Precio estable de las acciones: DHG no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de DHG (3%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | 2,789 | Toshiyuki Ishii | https://www.dhgpharma.com.vn |
DHG Pharmaceutical Joint Stock Company, junto con sus filiales, se dedica a la fabricación y venta de productos farmacéuticos principalmente en Vietnam. La empresa ofrece productos antibióticos, analgésicos y antipiréticos, respiratorios, nutricionales, musculoesqueléticos, gastrointestinales y hepatobiliares, nerviosos y oftálmicos, cardiovasculares y diabéticos, y dermatológicos y de belleza. También fabrica y comercializa suplementos para la salud y cosmecéuticos farmacéuticos.
DHG Pharmaceutical Joint Stock Company Fundamentals Summary
| DHG fundamental statistics | |
|---|---|
| Market cap | ₫15.09t |
| Earnings (TTM) | ₫1.02t |
| Revenue (TTM) | ₫5.02t |
14.8x
P/E Ratio3.0x
P/S RatioIs DHG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DHG income statement (TTM) | |
|---|---|
| Revenue | ₫5.02t |
| Cost of Revenue | ₫2.67t |
| Gross Profit | ₫2.34t |
| Other Expenses | ₫1.33t |
| Earnings | ₫1.02t |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.78k |
| Gross Margin | 46.73% |
| Net Profit Margin | 20.28% |
| Debt/Equity Ratio | 11.8% |
How did DHG perform over the long term?
See historical performance and comparison